Results 21 to 30 of about 149,015 (244)

Malignant Pleural Mesothelioma Treated in Clinic for Pulmonary Diseases and Tuberculosis “Podhrastovi“ in Ten-Year Period (from 1998 to 2007)

Biomolecules & Biomedicine, 2008
Malignant pleural mesothelioma (MPM) is the most common primary malign tumour of pleura. The aim of this study was to evaluate cases of MPM diagnosed and treated in Clinic for Pulmonary Diseases and Tuberculosis “Podhrastovi” during ten-year period (1998-
Vesna Čukić, Aida Ustamujić, Vladimir Lovre, Hasan Žutić, Sadika Genjac, Mina Mašić -Zečević   +5 more
doaj   +1 more source

The diagnostic performance of endobronchial ultrasound with Xpert MTB/RIF Ultra in smear-negative pulmonary tuberculosis

BMC Infectious Diseases, 2023
Objective This study investigated the diagnostic performance of endobronchial ultrasound with Xpert MTB/RIF Ultra (Ultra) for detecting smear-negative pulmonary tuberculosis (TB).
Lan Yao, Shanhao Chen, Wei Sha, Ye Gu
doaj   +1 more source

"HETEROSEROTHERAPY" IN PULMONARY TUBERCULOSIS. [PDF]

The Lancet, 1919
n ...
Perkins, J. J., Young, R. A., Meek, W. O.   +2 more
openaire   +3 more sources

PCR-reverse blot hybridization assay in respiratory specimens for rapid detection and differentiation of mycobacteria in HIV-negative population

BMC Infectious Diseases, 2021
Background Rapid identification of pathogenic Mycobacterium species is critical for a successful treatment. However, traditional method is time-consuming and cannot discriminate isolated non-tuberculosis mycobacteria (NTM) at species level.
Qing Zhang, Heping Xiao, Liping Yan
doaj   +1 more source

Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial

Emerging Microbes and Infections, 2023
In preclinical studies, a new antituberculosis drug regimen markedly reduced the time required to achieve relapse-free cure. This study aimed to preliminarily evaluate the efficacy and safety of this four-month regimen, consisting of clofazimine ...
Xubin Zheng, Xuwei Gui, Lan Yao, Jun Ma, Yifan He, Hai Lou, Jin Gu, Ruoyan Ying, Liping Chen, Qin Sun, Yidian Liu, Chih-Ming Ho, Bai-Yu Lee, Daniel L. Clemens, Marcus A. Horwitz, Xianting Ding, Xiaohui Hao, Hua Yang, Wei Sha   +18 more
doaj   +1 more source

TUBERCULIN IN PULMONARY TUBERCULOSIS [PDF]

BMJ, 1911
n ...
openaire   +5 more sources

The regulation and potential role of interleukin-32 in tuberculous pleural effusion

Frontiers in Immunology
The possible protective effect of interleukin-32 (IL-32) in Mycobacterium tuberculosis (Mtb) infection has been indicated. However, few studies have been focused on IL-32 in tuberculosis patients.
Xuan Wang, Chengqing Yang, Chao Quan, Jun Li, Yan Hu, Peng Liu, Lulu Guan, Li Li, Li Li   +8 more
doaj   +1 more source

Treatment of Pulmonary Tuberculosis

Medical Clinics of North America, 1956
n ...
Sokoloff, Martin J., Boucot, Katharine R.   +1 more
openaire   +3 more sources

THE NOTIFICATION OF PULMONARY TUBERCULOSIS. [PDF]

The Lancet, 1899
n ...
Pattin, H. Cooper, Pattin, H. Cooper
openaire   +2 more sources

Biodegradable, Humidity‐Insensitive Mask‐Integrated E‐Nose for Sustainable and Non‐Invasive Continuous Breath Analysis

Advanced Functional Materials, EarlyView.
This study introduces a paper‐based biodegradable, humidity‐insensitive e‐nose for real‐time breath analysis, addressing challenges in existing technologies such as humidity interference, high costs, and environmental impact. Featuring hydrophobic polymer coatings, these sensors reliably detect VOCs even in high‐moisture environments.
Indrajit Mondal, Adan Zoabi, Hossam Haick   +2 more
wiley   +1 more source